P495: Hunter syndrome and hemophilia A: A case of two X-linked syndromes occurring in one individual
Currently, the patient is treated with weekly infusions of Idursulfase (Elaprase), which is an enzyme replacement therapy for patients with Hunter syndrome, as well as Emicizumab (Hemlibra) for hemophilia A. A multidisciplinary team of specialists is involved in this patient’s care. He has received myringotomy tubes for recurrent ear infections and serial casting for hand, ankle, and elbow contractures.
Authors
- Anjana Bhami Shenoy
- Marta Biderman Waberski
Institutions
- Inova Children's Hospital (US)
Publication Details
- Journal
- Genetics in Medicine Open
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.gimo.2025.103362
- Primary Topic
- Biochemical and Molecular Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00